[Form 4] Medalist Diversified REIT, Inc. Insider Trading Activity
Frank Kavanaugh, Chairman, CEO & President of Medalist Diversified REIT, Inc. (MDRR), reported a series of open-market purchases increasing his direct beneficial ownership to 23,111 shares. The Form 4 shows purchases on 08/18/2025 (1 share at $10.85), 08/19/2025 (105 shares at $10.85) and 08/20/2025 (17,525 shares at a reported weighted-average $11.24). The filing notes the $11.24 figure is a weighted average for purchases made at prices ranging from $11.09 to $12.35 and the reporting person will provide details on request. The form is signed by Frank Kavanaugh on 08/20/2025.
- Insider purchases reported by the company's Chairman, CEO & President
- Direct beneficial ownership increased to 23,111 shares after the transactions
- Largest purchase recorded on 08/20/2025 for 17,525 shares at a reported weighted-average $11.24
- Filing includes explanatory footnote disclosing purchase price range ($11.09 to $12.35)
- None.
Insights
TL;DR: Insider purchases by the CEO increased direct holdings to 23,111 shares, signaling insider buying interest.
The reported transactions are outright open-market purchases by the companys Chairman, CEO and President across three dates, culminating in a reported direct beneficial ownership of 23,111 shares. The largest tranche on 08/20/2025 added 17,525 shares at a reported weighted-average price of $11.24, with an indicated price range of $11.09 to $12.35. From a financial-analyst perspective, concentrated insider buying by a senior executive is a noteworthy signal of confidence in the issuers equity, though the filing does not disclose the dollar value of each sub-transaction beyond the weighted-average note.
TL;DR: Filing is a standard Section 16 disclosure showing required reporting compliance for insider trades.
The Form 4 meets Section 16 reporting requirements by listing the reporting person, relationship to the issuer, transaction dates, codes and resulting beneficial ownership. It includes the required explanatory footnote about weighted-average pricing and a manual signature date. There are no options, derivatives, or amendments disclosed; this appears to be straightforward reporting of open-market purchases rather than a corporate action or plan change.